This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2007 Aug;3(8):430-1.

doi: 10.1038/ncprheum0535. Epub 2007 Jun 12.

Anti-TNF switching: effect on outcomes in patients with RA

Affiliations

Affiliation

¹ Division of Rheumatic Diseases, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. nancy.olsen@utsouthwestern.edu

PMID: 17563778
DOI: 10.1038/ncprheum0535

Comment

Anti-TNF switching: effect on outcomes in patients with RA

Nancy Olsen. Nat Clin Pract Rheumatol. 2007 Aug.

. 2007 Aug;3(8):430-1.

doi: 10.1038/ncprheum0535. Epub 2007 Jun 12.

Author

Affiliation

¹ Division of Rheumatic Diseases, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75390, USA. nancy.olsen@utsouthwestern.edu

PMID: 17563778
DOI: 10.1038/ncprheum0535

No abstract available

PubMed Disclaimer

Comment on

Outcomes after switching from one anti-tumor necrosis factor alpha agent to a second anti-tumor necrosis factor alpha agent in patients with rheumatoid arthritis: results from a large UK national cohort study.
Hyrich KL, Lunt M, Watson KD, Symmons DP, Silman AJ; British Society for Rheumatology Biologics Register. Hyrich KL, et al. Arthritis Rheum. 2007 Jan;56(1):13-20. doi: 10.1002/art.22331. Arthritis Rheum. 2007. PMID: 17195186

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.